Strategic Management of AstraZeneca

STRATEGIK
MANAGEMENT ASTRA
ZENECA

TABLE OF CONTENT
Introduction......................................................................................................................................1
Main body........................................................................................................................................1
Astra Zeneca and its sector..........................................................................................................1
Existing business strategy of company........................................................................................2
VRIO and strategic capabilities...................................................................................................2
Sustainability...............................................................................................................................4
Key findings.................................................................................................................................6
Recommendations........................................................................................................................6
Conclusion.......................................................................................................................................7
REFERENCES................................................................................................................................8

Introduction
Coronavirus has changed business for almost every industry. The pharma industry is under
constant pressure and are evolving with recent trends. Company like Astra Zeneca also framing
new business strategy in order to survive in such situation. Astra Zeneca is the multinational
pharma and biotechnology company. It has wide products which is helpful in fighting with
various diseases. Company got more famous during pandemic because of its major contribution
in COVID19 vacancies. This report will discuss company’s internal analysis relating to internal
approach of business strategy. Further existing business strategy and VRIO has discussed. This
report will also discuss sustainability, findings and recommendations.
Main body
Astra Zeneca and its sector
Ansoff matrix will be applied to ascertain internal analysis. It is an important instrument
created to work with and control company in choice relating to business development. It has four
elements:
Market penetration:
This strategy refers to growth with existing products in the existing market. Expanded creation
limit will permit AstraZeneca PLC to rise at more customer inside a same market. Expanded
appeal and competitive pricing inside a same market will prompt expanded deals and use – and
subsequently a higher market penetration.
Market development:
In this strategy existing products is launched in new market. The AstraZeneca PLC ought to
invest in research and development to see conceivable new business sectors and customer
portions for its products. Worldwide extension will permit AstraZeneca PLC to get to various
shopper gatherings, and increment its portion of the pie.
Product development:
This strategy refers to launch new products in the existing market (Namugenyi, Nimmagadda
and Reiners, 2019). The AstraZeneca PLC can present adjustments and update in existing
products to offer buyers new and improved contributions. The AstraZeneca PLC participates in
needful associations to investigate alternatives for item advancement too. The company can
likewise participate in new item advancement through presenting diverse quality items in a same
market.
1

Diversification:
The strategy refers to launch new products in the new market. Vertical diversification for the
AstraZeneca PLC imply searching for development and business advancement by presenting
new products under existing product offerings. The AstraZeneca PLC can likewise enhance into
turning into a conglomerate by taking part in an alternate business by and large (ANSOFF
MATRIX 101., 2020).
Existing business strategy of company
Driven by innovative science and our enterprising society, AstraZeneca is centered around
the conveyance of groundbreaking meds that are fuelling development and contributing worth to
patients. The essentials of organization methodology are clear. They focus on creative science
and administration in the three fundamental treatment zones: Oncology; Renal, Cardiovascular,
and Metabolism; and Respiratory infections. Sponsored by a worldwide presence, with strength
in Emerging Markets, especially China, they have an arrangement of forte and essential
consideration drugs. the world around is changing and the weight of sickness is expanding.
AstraZeneca is reacting by expanding center around development through advancement - being
more quiet driven, accomplishing more with innovation, computerized and information, and
propelling seriously bleeding edge science. Dispatching a consistent progression of forte
consideration items, adjusting the organization's memorable strength in essential consideration.
Remaking the R&D motor through advancement and particular science upheld by co-area
of our groups and better admittance to universally perceived science bunches. Significantly
working on the business, improving efficiency and building a culture that supports long haul
achievement. Utilizing business advancement and acquisitions to convey potential gain to the
organization's base arrangement and to fortify the pipeline further. We will change the manner in
which we complete innovative work. To help accomplish reasonable logical authority and
improve pipeline profitability, company will reshape the impression and advance the working
model. The formation of independent biologics and little atoms biotech units is intended to
improve advancement and speed up dynamic.
VRIO and strategic capabilities
This Analysis of AstraZeneca PLC will take a gander at every one of its inward assets
individually to evaluate whether these give sustained competitive advantage.
Valuable:
2